Technical University of Denmark   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Kongens Lyngby Denmark (1829)

Organization Overview

First Clinical Trial
2008
NCT01141803
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

National Food Institute, Technical University of Denmark | ParaTech A/S | Technical University of Denmark

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 1)

Colitis (Phase 2)

Colitis, Ulcerative (Phase 2)

Diabetes Mellitus (Phase 4)

Diabetes Mellitus, Type 1 (Phase 4)

Hypoglycemia (Phase 4)

Leukemia (Phase 2)

Leukemia, Myeloid (Phase 1)

Leukemia, Myeloid, Acute (Phase 1)

Leukemia, Myelomonocytic, Chronic (Phase 2)

Leukemia, Myelomonocytic, Juvenile (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Preleukemia (Phase 1)

Syndrome (Phase 1)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 21
  • # of Trial APIs: 25